Abstract
The progression of cancer has been closely-linked with augmentation of cellular reactive oxygen species (ROS) levels and ROS-Associated changes in the tumour microenvironment (TME), including alterations to the extracellular matrix and associated low drug uptake. Herein we report the application of a co-culture model to simulate the ROS based cell-cell interactions in the TME using fibroblasts and breast cancer cells, and describe how novel reactive polymers can be used to modulate those interactions. Under the co-culture conditions, both cell types exhibited modifications in behaviour, including significant overproduction of ROS in the cancer cells, and elevation of the collagen-1 secretion and stained actin filament intensity in the fibroblasts. To examine the potential of using reactive antioxidant polymers to intercept ROS communication and thereby manipulate the TME, we employed H2S-releasing macromolecular conjugates which have been previously demonstrated to mitigate ROS production in HEK cells. The specific conjugate used, mPEG-SSS-cholesteryl (T), significantly reduced ROS levels in co-cultured cancer cells by approximately 50%. This reduction was significantly greater than that observed with the other positive antioxidant controls. Exposure to T was also found to downregulate levels of collagen-1 in the co-cultured fibroblasts, while exhibiting less impact on cells in mono-culture. This would suggest a possible downstream effect of ROS-mitigation by T on stromal-Tumour cell signalling. Since fibroblast-derived collagens modulate crucial steps in tumorigenesis, this ROS-Associated effect could potentially be harnessed to slow cancer progression. The model may also be beneficial for interrogating the impact of antioxidants on naturally enhanced ROS levels, rather than relying on the application of exogenous oxidants to simulate elevated ROS levels.
| Original language | English |
|---|---|
| Pages (from-to) | 835-846 |
| Number of pages | 12 |
| Journal | Biomaterials Science |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 7 Feb 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Projects
- 5 Finished
-
Making chemotherapy curative: Blocking neural signalling to prevent TNBC relapse
Sloan, E. (Primary Chief Investigator (PCI)), Ilomaki, J. (Chief Investigator (CI)) & Botteri, E. (Chief Investigator (CI))
1/01/20 → 30/04/23
Project: Research
-
New materials for manipulating intracellular communication
Quinn, J. (Primary Chief Investigator (PCI))
5/07/17 → 5/05/22
Project: Research
-
Designing Nanoparticles to Combat Cellular Dysfunction
Whittaker, M. (Primary Chief Investigator (PCI)), Kaminskas, L. (Chief Investigator (CI)), Quinn, J. (Chief Investigator (CI)) & Sloan, E. (Chief Investigator (CI))
ARC - Australian Research Council, Monash University
1/01/17 → 31/12/19
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver